AI
TMO icon

Accredited Investors’s Thermo Fisher Scientific TMO Stock Holding History

Accredited Investors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508K Sell
1,013
-148
-13% -$71K 0.02% 178
2026
Q1 		$571K Sell
1,161
-407
-26% -$221K 0.03% 144
2025
Q4 		$909K Buy
1,568
+350
+29% +$198K 0.05% 113
2025
Q3 		$591K Buy
1,218
+300
+33% +$140K 0.03% 135
2025
Q2 		$372K Sell
918
-7
-0.8% -$2.93K 0.02% 163
2025
Q1 		$460K Sell
925
-33
-3% -$17.9K 0.03% 132
2024
Q4 		$498K Sell
958
-23
-2% -$12.6K 0.03% 131
2024
Q3 		$607K Buy
981
+75
+8% +$44.4K 0.03% 120
2024
Q2 		$501K Hold
906
– – 0.03% 122
2024
Q1 		$527K Buy
906
+70
+8% +$39.3K 0.03% 123
2023
Q4 		$444K Hold
836
– – 0.03% 128
2023
Q3 		$423K Hold
836
– – 0.03% 123
2023
Q2 		$436K Hold
836
– – 0.03% 122
2023
Q1 		$482K Sell
836
-4
-0.5% -$2.25K 0.04% 114
2022
Q4 		$463K Sell
840
-8
-0.9% -$4.24K 0.04% 108
2022
Q3 		$430K Buy
848
+2
+0.2% +$1.12K 0.05% 105
2022
Q2 		$460K Sell
846
-7
-0.8% -$3.85K 0.05% 103
2022
Q1 		$504K Sell
853
-59
-6% -$33.9K 0.05% 111
2021
Q4 		$609K Buy
+912
New +$569K 0.05% 99
2020
Q2 		– Sell
-895
Closed -$254K – 140
2020
Q1 		$254K Sell
895
-176
-16% -$55.5K 0.06% 111
2019
Q4 		$348K Buy
1,071
+176
+20% +$53.4K 0.06% 103
2019
Q3 		$261K Sell
895
-264
-23% -$75.6K 0.05% 115
2019
Q2 		$340K Hold
1,159
– – 0.07% 103
2019
Q1 		$317K Hold
1,159
– – 0.06% 104
2018
Q4 		$259K Hold
1,159
– – 0.06% 103
2018
Q3 		$283K Buy
+1,159
New +$267K 0.07% 99

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Accredited Investors's TMO Position: Q2 2026 in Review

Accredited Investors reduced its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, selling an estimated $71K and leaving 1,013 shares worth $508K. The position accounts for 0.02% of the portfolio, ranked #178.

Accredited Investors first reported a position in TMO in Q3 2018 and has held it in 26 quarters since. The position peaked at $909K in Q4 2025. 1,170 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Accredited Investors held 1,013 shares of Thermo Fisher Scientific worth $508K as of Q2 2026.
  • Accredited Investors sold 148 Thermo Fisher Scientific shares in Q2 2026, an estimated $71K.
  • Thermo Fisher Scientific made up 0.02% of Accredited Investors's portfolio in Q2 2026, its #178 holding.
  • Accredited Investors first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 26 quarters since.
  • Accredited Investors's Thermo Fisher Scientific position peaked at $909K in Q4 2025.
  • 1,170 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.